|
|
|
Board of Directors
Members of Flexible Stenting Solutions' Board of Directors have led various companies from early stage development through commercialization. The Board is composed of the following individuals:
- Janet Burpee, CEO
- Steve Burpee, COO Burpee Materials Technology
- Gary Cantrell, CEO Yasoo Health Inc.
- Gary Johnson, CEO Tube Methods
- Douglas Lind, M.D. Managing Partner, GBP Capital
- Robert Portman, CEO Pacific Health Labs
- Michael Walsh, First VP for Office of General Counsel, Merrill Lynch
- David Wetherell, Founder and Managing Partner, GBP Capital
|
|
